SCHEMBL3257464

SCHEMBL3257464

CCOC(=O)/C(C)=N/NC.Cc1sc(-c2ccc(Cl)cc2)nc1CC(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN11 Q06124 2/20 0.47
MAPT P10636 4/20 0.44
TRPM8 Q7Z2W7 1/20 0.44
RAB9A P51151 4/20 0.44
SMN1; SMN2 Q16637 4/20 0.43
NPC1 O15118 3/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
NFKB1 P19838 1/20 0.43
NFKB2 Q00653 1/20 0.43
RELA Q04206 1/20 0.43
PTGDR2 Q9Y5Y4 6/20 0.41
KDM4E B2RXH2 3/20 0.41
POLB P06746 1/20 0.41
GAA P10253 1/20 0.41
ALDH1A1 P00352 4/20 0.40
CYP2C9 P11712 3/20 0.40
CYP1A2 P05177 2/20 0.40
CYP2C19 P33261 2/20 0.40
HPGD P15428 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3257467 1.00 PTPN11 (0.47) PTPN11MAPTTRPM8RAB9ASMN1; SMN2
SCHEMBL3065774 0.82 PTGDR2 (0.56) PTPN11MAPTTRPM8RAB9ASMN1; SMN2
SCHEMBL3257465 0.78 PTPN11 (0.44) PTPN11MAPTTRPM8RAB9ASMN1; SMN2
SCHEMBL4905523 0.77 MAPT (0.56) PTPN11MAPTTRPM8RAB9ASMN1; SMN2
SCHEMBL4462240 0.72 KDM4E (0.57) MAPTTRPM8RAB9AMEN1KMT2A
SCHEMBL13761092 0.71 PTPN11 (0.47) PTPN11MAPTTRPM8RAB9ASMN1; SMN2
SCHEMBL13761085 0.71 SHMT1 (0.49) PTPN11MAPTTRPM8RAB9ASMN1; SMN2
SCHEMBL3537226 0.70 PTGDR2 (0.56) SMN1; SMN2PTGDR2KDM4EPOLBALDH1A1
SCHEMBL9555373 0.69 PTGDR2 (0.58) MAPTRAB9ASMN1; SMN2NPC1MEN1
SCHEMBL5937272 0.69 PTPN11 (0.72) PTPN11MAPTTRPM8RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2225211-B1 HERBICIDAL PYRIDAZINONE DERIVATIVES DU PONT (US) 2013-10-02 EP disclosed
US-20100267561-A1 HERBICIDAL PYRIDAZINONE DERIVATIVES E. I. DU PONT DE NEMOURS AND COMPANY 2010-10-21 US disclosed
EP-2225211-A1 HERBICIDAL PYRIDAZINONE DERIVATIVES E. I. du Pont de Nemours and Company (US) 2010-09-08 EP disclosed
WO-2009086041-A1 HERBICIDAL PYRIDAZINONE DERIVATIVES E. I. DU PONT DE NEMOURS AND COMPANY (US) 2009-07-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100267561-A1 HERBICIDAL PYRIDAZINONE DERIVATIVES CYP1A1, CYP1B1, CBR3 PTPN11 520/4885MAPT 4370/4885TRPM8 4005/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.